FindTrial
Sign In

To investigate the effect and mechanism of amniotic mesenchymal stem cells in the treatment of intrauterine adhesion.

To investigate the effect and mechanism of amniotic mesenchymal stem cells in the treatment of intrauterine adhesion.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16008605
Enrollment
Unknown
Registered
2016-06-07
Start date
2016-06-07
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine adhesions

Interventions

Case series:amniotic mesenchymal stem cells

Sponsors

University-Town Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Normal term selective cesarean section, no infectious disease, amniotic fluid, maternal voluntary to give up and donate the scientific research of abandoned placenta.

Exclusion criteria

Exclusion criteria: Age less than 18 years old or above 40 years old, suffering from infectious diseases such as hepatitis B, hepatitis C, syphilis, AIDS, gonorrhea and other, suffering from severe maternal disease (such as intrahepatic cholestasis, fetal distress, placenta implantation).

Design outcomes

Primary

MeasureTime frame
cytokines;cell surface marker;—

Countries

China

Contacts

Public ContactJia Wang

University-Town Hospital of Chongqing Medical University

752203031@qq.com+86 13508307321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026